Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

cediranib 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Advanced Tumor × Clear all
NCT05839106 2023-05-06

Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors

Biotheus Inc.

Phase 1/2 Unknown
200 enrolled

Advanced Tumor

NCT05108779 2023-03-28

QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1 Unknown
40 enrolled

Advanced Tumor

NCT05607563 2023-02-08

A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours

Biotheus Inc.

Phase 1 Unknown
54 enrolled

Advanced Tumor

NCT00502060 2009-05-14

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

AstraZeneca

Phase 1 Completed
65 enrolled

Advanced Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡